Names,Fstat,p.value,q.value,AFR,EUR,AMR,SAS,EAS,medFilter
Asparaginase hypersensitivity in acute lymphoblastic leukemia.txt,585.1, < 5e-324, < 5e-324,0,1,0,1,0,1
Aspirin hydrolysis plasma.txt,5, < 5e-324, < 5e-324,0,0,0,0,0,1
Black vs. blond hair color.txt,719.2, < 5e-324, < 5e-324,4,1,3,2,3,1
Black vs. red hair color.txt,625.5, < 5e-324, < 5e-324,4,1,3,2,3,1
Conduct disorder interaction.txt,5.8, < 5e-324, < 5e-324,1,1,1,1,2,1
Crohns disease and celiac disease.txt,566, < 5e-324, < 5e-324,3,2,2,1,1,1
Diabetes gestational.txt,592.6, < 5e-324, < 5e-324,2,1,1,1,1,1
Diabetic kidney disease.txt,577, < 5e-324, < 5e-324,2,1,1,1,1,1
Diisocyanate-induced asthma.txt,2315.9, < 5e-324, < 5e-324,24,14,18,17,20,0
Fetal hemoglobin levels.txt,515.3, < 5e-324, < 5e-324,2,2,2,2,2,1
Hair color.txt,1000.3, < 5e-324, < 5e-324,2,1,2,2,2,1
Idiopathic pulmonary fibrosis.txt,4.9, < 5e-324, < 5e-324,1,1,1,1,1,1
Immunoglobulin A.txt,515.8, < 5e-324, < 5e-324,4,1,1,2,2,1
Methotrexate phramacokinetics acute lymphoblastic leukemia.txt,898.5, < 5e-324, < 5e-324,2,4,4,4,3,1
Neuritic plaque.txt,5, < 5e-324, < 5e-324,0,0,0,0,0,1
Obesity-related traits.txt,2172.1, < 5e-324, < 5e-324,113,89,86,92,96,1
Optic disc area.txt,586.2, < 5e-324, < 5e-324,5,4,4,4,3,1
Perceived skin darkness.txt,640.4, < 5e-324, < 5e-324,2,1,2,2,2,1
Pulmonary function interaction.txt,4.8, < 5e-324, < 5e-324,9,10,9,9,9,0
Recalcitrant atopic dermatitis.txt,529.4, < 5e-324, < 5e-324,2,2,2,2,1,1
Schizophrenia.txt,663.3, < 5e-324, < 5e-324,176,172,171,170,169,0
Skin colour saturation.txt,774.4, < 5e-324, < 5e-324,0,0,0,0,0,1
Type 2 diabetes nephropathy.txt,526.3, < 5e-324, < 5e-324,1,1,1,1,0,1
Upper aerodigestive tract cancers.txt,481.6,3.80E-308,3.10E-305,2,0,1,1,2,1
Lobe size.txt,479.9,2.60E-307,2.10E-304,0,0,1,1,1,1
Blue vs. green eyes.txt,477,6.90E-306,5.60E-303,0,0,0,0,0,1
Clozapine-induced agranulocytosis.txt,466,1.90E-300,1.60E-297,2,2,2,2,1,1
Glycerophospholipid levels.txt,449.2,5.00E-292,4.00E-289,14,10,9,10,10,0
Prostate cancer early onset.txt,448.4,1.30E-291,1.10E-288,3,1,2,2,1,1
IgG levels.txt,430.8,1.20E-282,1.00E-279,2,1,1,1,2,1
Immunoglobulin G index levels in multiple sclerosis.txt,415.2,1.40E-274,1.10E-271,0,0,0,0,0,1
Glycemic traits pregnancy.txt,405.1,2.50E-269,2.00E-266,2,3,3,2,2,1
Bone mineral density paediatric skull.txt,404.9,3.40E-269,2.80E-266,7,6,6,5,5,1
Primary tooth development number of teeth.txt,401.2,3.00E-267,2.40E-264,4,3,3,4,4,1
Alcoholism alcohol use disorder factor score.txt,396.9,6.00E-265,4.80E-262,3,5,4,5,4,1
Progression free survival in metastatic colorectal cancer CAPOX-B vs CAPOX-B plus cetuximab.txt,395.4,3.70E-264,2.90E-261,1,0,0,0,0,1
Type 2 diabetes.txt,393.5,3.70E-263,2.90E-260,43,42,42,45,46,0
Tumor biomarkers.txt,392.6,1.10E-262,8.80E-260,1,0,0,1,2,1
Word reading.txt,383.2,1.20E-257,1.00E-254,4,7,6,5,5,1
Urate levels.txt,373.4,2.30E-252,1.80E-249,23,26,25,26,28,0
Circulating myeloperoxidase levels serum.txt,368.8,7.20E-250,5.70E-247,2,0,1,1,1,1
Nicotine dependence.txt,366.3,1.80E-248,1.40E-245,0,1,1,0,0,1
Menarche and menopause age at onset.txt,356.6,3.90E-243,3.10E-240,1,0,0,0,0,1
Amyotrophic lateral sclerosis.txt,350.5,9.10E-240,7.10E-237,6,3,4,4,4,1
Airway responsiveness in chronic obstructive pulmonary disease.txt,346.2,2.40E-237,1.80E-234,0,0,0,0,0,1
Non-small cell lung cancer.txt,345.9,3.10E-237,2.40E-234,0,1,0,1,0,1
Fractional exhaled nitric oxide childhood.txt,345.1,9.00E-237,7.00E-234,1,1,1,1,1,1
Myopia pathological.txt,340.4,4.10E-234,3.10E-231,3,2,2,2,3,1
Blood and toenail selenium levels.txt,335,4.10E-231,3.20E-228,2,1,1,2,2,1
QT interval interaction.txt,334.5,8.50E-231,6.60E-228,13,11,11,11,11,0
Wilms tumor.txt,332.7,8.50E-230,6.60E-227,1,0,0,0,0,1
Breast cancer survival.txt,326.7,2.10E-226,1.60E-223,2,1,0,0,0,1
Waist-to-hip ratio adjusted for body mass index.txt,326.7,2.10E-226,1.60E-223,21,23,21,23,25,0
Lentiform nucleus volume.txt,324.4,4.50E-225,3.40E-222,1,2,2,2,3,1
Renal function-related traits urea.txt,320.9,4.50E-223,3.40E-220,2,0,1,1,2,1
Thyroid peroxidase antibody levels.txt,319.3,3.50E-222,2.70E-219,0,0,0,0,0,1
Blood pressure measurement cold pressor test.txt,319.3,3.90E-222,3.00E-219,0,0,0,0,1,1
Leprosy.txt,317.5,3.90E-221,3.00E-218,7,9,9,10,9,0
Hematology traits.txt,315.7,4.70E-220,3.60E-217,2,4,3,3,3,1
Visceral adipose tissuesubcutaneous adipose tissue ratio.txt,312.5,3.30E-218,2.50E-215,7,9,9,8,9,0
Waist circumference.txt,312.3,4.20E-218,3.20E-215,7,5,5,5,5,1
Bone mineral density.txt,309.6,1.50E-216,1.10E-213,36,35,34,37,36,0
Vertical cup-disc ratio.txt,308.2,9.60E-216,7.30E-213,4,2,2,2,2,1
Forced expiratory volume in 1 second environmental interaction.txt,302.3,2.50E-212,1.90E-209,2,1,1,2,3,1
Homeostasis model assessment of beta-cell function interaction.txt,291.2,9.40E-206,7.10E-203,4,3,3,2,3,1
Triglycerides.txt,287.8,8.60E-204,6.50E-201,11,13,13,15,14,0
Cholesterol total.txt,286.1,9.20E-203,6.90E-200,19,20,19,21,20,0
Blond vs. brown hair color.txt,286,1.00E-202,7.60E-200,0,0,0,0,0,1
Attention deficit hyperactivity disorder time to onset.txt,285.4,2.30E-202,1.70E-199,4,4,4,5,5,1
Type 1 diabetes and autoimmune thyroid diseases.txt,285.3,2.70E-202,2.00E-199,1,1,2,1,3,1
Bone properties heel.txt,284.8,5.50E-202,4.10E-199,2,2,2,2,3,1
Subcortical brain region volumes.txt,282.3,1.70E-200,1.30E-197,1,3,2,2,1,1
Hypothyroidism.txt,282,2.50E-200,1.90E-197,7,5,5,5,6,1
Brugada syndrome.txt,281.5,4.90E-200,3.70E-197,0,1,1,1,0,1
QRS duration.txt,276.6,4.50E-197,3.30E-194,4,6,5,6,5,1
Skin sensitivity to sun.txt,272.4,1.40E-194,1.10E-191,0,0,0,0,0,1
Hippocampal volume.txt,270.1,3.70E-193,2.80E-190,5,4,4,4,4,1
Sexual dimorphism in anthropometric traits.txt,269.8,5.90E-193,4.40E-190,5,5,5,6,6,1
Male fertility.txt,267.9,8.10E-192,6.00E-189,0,0,0,0,0,1
Non-albumin protein levels.txt,266.6,5.00E-191,3.70E-188,2,0,1,1,1,1
Resistin levels.txt,265.2,3.60E-190,2.60E-187,2,0,0,1,1,1
Glycemic traits.txt,265.1,4.10E-190,3.00E-187,0,0,0,0,0,1
Urinary metabolites H-NMR features.txt,258,8.40E-186,6.10E-183,2,5,5,5,5,1
Chronic myeloid leukemia.txt,254.8,8.20E-184,6.00E-181,2,0,1,1,2,1
Frontotemporal dementia.txt,253.6,4.10E-183,3.00E-180,2,3,4,4,4,1
Pulmonary emphysema.txt,252.9,1.10E-182,8.30E-180,2,2,2,2,2,1
Serum total protein level.txt,253,1.10E-182,8.10E-180,1,2,2,2,2,1
Serum tamsulosin hydrochloride concentration.txt,252.3,2.90E-182,2.10E-179,1,2,2,1,2,1
Overweight status.txt,252,4.50E-182,3.30E-179,1,0,0,0,0,1
Plasma plasminogen activator levels.txt,251.3,1.20E-181,9.10E-179,4,4,3,3,3,1
Gamma glutamyl transpeptidase.txt,249.8,1.00E-180,7.60E-178,0,0,0,0,0,1
Allergic sensitization.txt,249.1,2.80E-180,2.00E-177,7,10,9,9,8,0
Brain structure.txt,248,1.30E-179,9.90E-177,2,1,1,0,0,1
Glioma high-grade.txt,244.7,1.40E-177,1.00E-174,4,3,3,3,1,1
Prostate cancer.txt,244.3,2.40E-177,1.70E-174,19,21,21,21,20,0
Seasonality.txt,243.6,7.20E-177,5.20E-174,3,3,3,3,2,1
Thyroid hormone levels.txt,242.4,4.10E-176,3.00E-173,8,11,10,11,8,0
Gene methylation in lung tissue.txt,239.3,3.40E-174,2.40E-171,1,0,0,0,0,1
Rheumatoid arthritis.txt,238.6,9.00E-174,6.40E-171,29,30,31,29,32,0
Biochemical measures.txt,238.5,1.00E-173,7.30E-171,3,1,2,2,2,1
Acute lymphoblastic leukemia childhood.txt,237.8,3.00E-173,2.10E-170,5,4,5,5,5,1
Blood pressure measurement low sodium intervention.txt,235.5,7.90E-172,5.60E-169,1,0,0,0,0,1
Cerivastatin-induced rhabdomyolysis.txt,234.9,2.10E-171,1.50E-168,2,1,1,2,2,1
Optic disc parameters.txt,234.3,4.70E-171,3.30E-168,2,0,1,0,1,1
Coronary heart disease.txt,233.8,9.20E-171,6.60E-168,9,8,9,10,12,0
Cutaneous malignant melanoma.txt,232.9,3.80E-170,2.70E-167,2,3,2,2,2,1
Pulmonary function in asthmatics.txt,232.6,5.40E-170,3.80E-167,2,2,2,2,1,1
Acylcarnitine levels.txt,232.3,9.10E-170,6.50E-167,6,7,7,7,8,1
Alzheimers disease in APOE e4- carriers.txt,231.8,1.60E-169,1.20E-166,2,1,1,1,1,1
Pancreatitis.txt,229.5,4.90E-168,3.50E-165,1,2,2,1,1,1
Large artery stroke.txt,229,1.00E-167,7.20E-165,1,1,1,1,1,1
Attention deficit hyperactivity disorder and conduct disorder.txt,228,4.40E-167,3.10E-164,11,10,9,9,9,0
Yu-Zhi constitution type in type 2 diabetes.txt,226.8,2.60E-166,1.80E-163,3,4,4,5,4,1
Renal function-related traits BUN.txt,225.5,1.80E-165,1.20E-162,1,1,1,1,1,1
Infant length.txt,225.4,2.00E-165,1.40E-162,3,4,4,5,5,1
Developmental dysplasia of the hip.txt,224.5,7.50E-165,5.30E-162,0,1,1,1,2,1
Smooth-surface caries.txt,223.9,2.00E-164,1.40E-161,12,15,15,15,15,0
Obesity early onset extreme.txt,223.6,2.90E-164,2.00E-161,6,4,4,4,4,1
Suicide ideation score in major depressive disorder.txt,223.5,3.60E-164,2.50E-161,2,0,0,1,0,1
Testicular cancer.txt,217.3,3.10E-160,2.10E-157,2,3,3,3,3,1
Self-rated health.txt,215.6,4.10E-159,2.90E-156,2,2,1,2,1,1
Antitragus size.txt,215.5,4.80E-159,3.30E-156,0,0,1,0,1,1
Anxiety disorder.txt,215.1,8.20E-159,5.70E-156,3,2,2,2,1,1
Current cigarettes per day in chronic obstructive pulmonary disease.txt,213.9,5.00E-158,3.40E-155,2,2,2,2,2,1
Blood pressure measurement high sodium intervention.txt,213.5,9.60E-158,6.60E-155,0,1,1,0,0,1
Cardiac Troponin-T levels.txt,212.9,2.20E-157,1.50E-154,4,4,3,4,3,1
Sleep quality.txt,212.5,4.20E-157,2.90E-154,3,1,1,1,2,1
Plasma amyloid beta peptide concentrations ABx-40.txt,210.8,5.30E-156,3.60E-153,0,0,0,0,0,1
Myocardial infarction early onset.txt,210.3,1.00E-155,7.10E-153,3,4,4,4,4,1
Bladder cancer.txt,208.4,1.60E-154,1.10E-151,4,5,5,5,5,1
AD Atopic dermatitis from AV.txt,207.3,9.80E-154,6.70E-151,3,3,2,2,1,1
Chronic kidney disease.txt,206.7,2.20E-153,1.50E-150,4,4,3,3,2,1
Mortality in heart failure.txt,205.7,1.10E-152,7.50E-150,3,2,2,2,3,1
Systolic blood pressure in sickle cell anemia.txt,205.4,1.50E-152,1.00E-149,6,7,7,7,7,1
Optic cup area.txt,205,2.70E-152,1.80E-149,2,2,2,2,1,1
Activated partial thromboplastin time.txt,203.8,1.60E-151,1.10E-148,4,4,4,4,4,1
Ankle-brachial index.txt,202.4,1.40E-150,9.70E-148,2,1,1,1,1,1
Thyroid peroxidase antibody positivity.txt,199.7,8.10E-149,5.50E-146,1,2,2,2,2,1
Obesity extreme.txt,199.3,1.60E-148,1.10E-145,0,1,1,1,1,1
Bone mineral density paediatric lower limb.txt,198.3,7.10E-148,4.80E-145,6,5,4,4,3,1
Bronchodilator response in asthma inhaled corticosteroid treatment interaction.txt,197.2,3.60E-147,2.40E-144,0,0,0,0,1,1
Hepatitis B.txt,194.6,1.90E-145,1.20E-142,0,0,0,0,0,1
Age at smoking initiation in chronic obstructive pulmonary disease.txt,194.2,3.70E-145,2.40E-142,3,4,4,4,4,1
Circulating myeloperoxidase levels plasma.txt,191.6,1.80E-143,1.20E-140,2,3,3,3,3,1
IgA nephropathy.txt,191.1,4.20E-143,2.80E-140,5,4,4,3,4,1
Serum metabolite levels.txt,189.9,2.70E-142,1.80E-139,6,6,6,5,7,1
Blood trace element Zn levels.txt,189.5,4.90E-142,3.20E-139,0,1,1,1,1,1
Calcium levels.txt,189.5,5.00E-142,3.30E-139,6,7,7,8,7,1
Periodontitis PAL4Q3.txt,188.9,1.20E-141,8.10E-139,4,6,5,6,6,1
Fibrinogen.txt,187.9,5.80E-141,3.90E-138,13,14,12,14,14,0
RA Rheumatoid arthritis from AV.txt,187.7,7.70E-141,5.10E-138,81,75,79,73,74,0
Non-alcoholic fatty liver disease histology other.txt,186.9,2.40E-140,1.60E-137,6,8,8,8,8,1
Blood trace element Cu levels.txt,186.7,3.20E-140,2.10E-137,1,2,2,2,2,1
Retinal arteriolar caliber.txt,186.3,6.80E-140,4.50E-137,4,3,3,3,2,1
Cardiac repolarization.txt,185.9,1.20E-139,8.30E-137,1,2,2,1,3,1
Life threatening arrhythmia.txt,185.6,1.70E-139,1.10E-136,2,2,2,2,1,1
vWF and FVIII levels.txt,185,4.70E-139,3.10E-136,1,1,1,1,0,1
IBD Inflammatory bowel disease from AV.txt,184.1,1.90E-138,1.20E-135,86,91,94,93,92,0
Creutzfeldt-Jakob disease sporadic.txt,181.7,8.20E-137,5.40E-134,1,1,1,1,2,1
MGMT methylation in smokers.txt,181.6,8.30E-137,5.50E-134,0,1,0,1,1,1
Celiac disease or Rheumatoid arthritis.txt,181.6,8.90E-137,5.80E-134,0,1,0,1,0,1
Inflammatory biomarkers in Kawasaki disease.txt,181.2,1.60E-136,1.00E-133,1,0,0,0,0,1
Restless legs syndrome.txt,178.1,2.10E-134,1.30E-131,2,3,3,3,3,1
Urate levels in overweight individuals.txt,177.5,4.80E-134,3.10E-131,7,5,6,6,6,1
Hemoglobin A2 levels in sickle cell anemia.txt,174.7,4.20E-132,2.70E-129,1,0,0,0,0,1
Crohns disease and psoriasis.txt,173.8,1.60E-131,1.10E-128,2,1,2,1,2,1
Stroke ischemic.txt,173.4,3.20E-131,2.10E-128,1,1,1,1,1,1
White matter hyperintensity burden.txt,172.9,6.40E-131,4.10E-128,5,5,5,4,4,1
Cataracts in type 2 diabetes.txt,172.3,1.70E-130,1.10E-127,0,0,0,0,0,1
Menarche age at onset.txt,172,2.80E-130,1.80E-127,56,51,52,54,53,0
Plasma omega-6 polyunsaturated fatty acid levels linoleic acid.txt,171.7,4.40E-130,2.80E-127,2,1,1,1,1,1
Percent mammographic density.txt,171.5,6.20E-130,3.90E-127,4,3,3,4,2,1
Cognitive function.txt,171.3,7.80E-130,5.00E-127,2,1,1,1,1,1
Tourettes syndrome or obsessive-compulsive disorder.txt,171.1,1.00E-129,6.80E-127,2,1,1,1,0,1
Lung cancer asbestos exposure interaction.txt,170.8,1.70E-129,1.10E-126,0,0,0,1,1,1
Folding of antihelix.txt,169.9,7.70E-129,4.90E-126,1,2,2,2,1,1
Body mass index in asthmatics.txt,169.6,1.10E-128,7.40E-126,1,0,0,0,1,1
Urate levels BMI interaction.txt,169.5,1.20E-128,8.10E-126,2,2,2,2,2,1
Hematological and biochemical traits.txt,169.5,1.30E-128,8.60E-126,2,3,2,2,3,1
Asthma childhood onset.txt,168.7,4.40E-128,2.80E-125,1,2,2,2,2,1
Local histogram emphysema pattern.txt,168.3,9.00E-128,5.70E-125,5,4,5,5,5,1
Multiple myeloma IgH translocation.txt,168.2,1.00E-127,6.90E-125,6,4,4,4,4,1
Tanning.txt,167.1,5.90E-127,3.70E-124,1,1,1,1,0,1
Sagittal craniosynostosis.txt,166.9,7.90E-127,4.90E-124,2,1,1,2,2,1
Pulmonary arterial hypertension without BMPR2 mutations.txt,166.7,1.10E-126,7.00E-124,1,0,0,0,0,1
Freckles.txt,166.2,2.50E-126,1.60E-123,0,0,0,0,0,1
DNA methylation parent-of-origin.txt,165.8,4.20E-126,2.60E-123,2,3,3,3,3,1
Neurofibrillary tangles.txt,163.5,1.80E-124,1.10E-121,4,3,3,3,3,1
Suicide in bipolar disorder.txt,163.3,2.10E-124,1.30E-121,2,2,2,2,2,1
Nicotine use.txt,162.9,4.20E-124,2.60E-121,3,2,2,2,2,1
Lymphoma.txt,162.7,5.80E-124,3.60E-121,3,1,1,1,0,1
Male-pattern baldness.txt,162.3,1.10E-123,7.40E-121,3,3,3,3,3,1
Bilirubin levels.txt,160.3,2.80E-122,1.70E-119,5,4,4,4,5,1
Creutzfeldt-Jakob disease.txt,159.8,5.50E-122,3.40E-119,2,2,2,2,3,1
Non-small cell lung cancer survival.txt,159.2,1.60E-121,1.00E-118,1,2,2,2,2,1
Prostate-specific antigen levels.txt,158.6,4.00E-121,2.40E-118,0,0,0,0,0,1
Alcohol and nictotine co-dependence.txt,158,1.00E-120,6.60E-118,1,0,0,0,0,1
Free thyroxine concentration.txt,157.8,1.40E-120,9.20E-118,2,1,1,1,0,1
Personality dimensions.txt,157.3,3.20E-120,2.00E-117,4,5,5,6,5,1
Conduct disorder.txt,155.6,5.10E-119,3.10E-116,1,1,1,1,1,1
PBC Primary biliary cirrhosis from AV.txt,154.7,2.00E-118,1.20E-115,9,11,12,10,12,0
Adiponectin levels.txt,153.8,7.90E-118,4.80E-115,7,6,7,6,8,1
Sudden cardiac arrest.txt,153.5,1.40E-117,8.70E-115,1,0,0,0,0,1
IgM levels.txt,153,2.90E-117,1.70E-114,4,4,4,4,3,1
Dehydroepiandrosterone sulphate levels.txt,152.5,6.60E-117,4.00E-114,0,0,0,0,0,1
Aging time to event.txt,152.4,7.50E-117,4.60E-114,2,3,3,2,3,1
Sunburns.txt,151.1,6.10E-116,3.70E-113,1,1,1,1,1,1
Lipoprotein-associated phospholipase A2 activity and mass.txt,151.1,6.90E-116,4.20E-113,5,5,6,5,6,1
Acute kidney injury in coronary artery bypass surgery creatinine rise.txt,150.5,1.70E-115,1.00E-112,0,0,0,0,0,1
Information processing speed.txt,150.2,2.60E-115,1.50E-112,12,10,10,10,9,0
Immune response to smallpox vaccine IL-6.txt,149.7,6.30E-115,3.80E-112,0,0,0,0,0,1
"Schizophrenia, bipolar disorder and depression combined.txt",147.9,1.10E-113,7.20E-111,1,1,2,2,2,1
Non-melanoma skin cancer.txt,147.8,1.20E-113,7.40E-111,0,0,0,0,0,1
Fractional exhaled nitric oxide levels.txt,147.6,1.90E-113,1.10E-110,1,1,1,1,2,1
Lead levels in blood.txt,147.5,2.10E-113,1.30E-110,11,10,11,11,12,0
Birth weight.txt,146.5,1.10E-112,6.80E-110,1,2,2,2,3,1
Forced vital capacity.txt,145.6,4.30E-112,2.60E-109,2,1,1,2,2,1
Thiazide-induced adverse metabolic effects in hypertensive patients.txt,145,1.20E-111,7.10E-109,9,9,10,9,10,0
Alcohol consumption transferrin glycosylation.txt,144.9,1.30E-111,7.80E-109,2,2,2,3,2,1
Optic nerve measurement rim area.txt,144.9,1.50E-111,8.90E-109,2,2,2,2,2,1
Liver enzyme levels aspartate transaminase.txt,144.8,1.60E-111,9.70E-109,0,0,0,1,0,1
Behcets disease.txt,144.5,2.60E-111,1.50E-108,4,2,2,3,3,1
C-reactive protein levels.txt,144.3,3.60E-111,2.10E-108,5,5,5,5,6,1
Abdominal aortic aneurysm.txt,143.9,6.60E-111,3.90E-108,1,0,0,1,0,1
Peak creatinine levels in vancomycin therapy.txt,143.6,1.10E-110,6.90E-108,2,0,1,1,1,1
Cystic fibrosis severity.txt,143.6,1.20E-110,7.20E-108,0,1,0,0,0,1
Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid.txt,143.4,1.70E-110,1.00E-107,4,4,4,4,5,1
Blood pressure age interaction.txt,143.2,2.10E-110,1.20E-107,2,2,2,2,3,1
Crohns disease-related phenotypes.txt,143.2,2.10E-110,1.20E-107,1,0,0,0,0,1
Primary tooth development time to first tooth eruption.txt,143.1,2.40E-110,1.40E-107,3,3,3,4,5,1
Migraine - clinic-based.txt,142.6,6.20E-110,3.60E-107,3,4,3,3,3,1
Hepatitis B viral clearance.txt,142.3,1.00E-109,6.00E-107,0,0,1,1,1,1
Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid.txt,141.9,1.70E-109,1.00E-106,3,3,3,2,3,1
Iron status biomarkers.txt,141.5,3.20E-109,1.80E-106,4,4,5,5,5,1
Haptoglobin levels.txt,141.4,4.00E-109,2.30E-106,0,0,0,1,0,1
Permanent tooth development.txt,141,8.40E-109,4.80E-106,3,2,2,2,2,1
Gastritis.txt,140.8,1.00E-108,6.20E-106,0,0,0,0,0,1
Depressive symptoms SSRI exposure interaction.txt,140.3,2.50E-108,1.40E-105,2,3,3,3,4,1
Platelet count.txt,140,4.20E-108,2.40E-105,13,14,14,13,13,0
Autism spectrum disorder.txt,139.8,5.90E-108,3.40E-105,0,0,0,0,0,1
Irritable bowel syndrome.txt,139.4,1.10E-107,6.40E-105,1,1,1,1,0,1
Hand grip strength.txt,139,2.00E-107,1.10E-104,0,0,0,0,0,1
Lung cancer smoking interaction.txt,138.9,2.20E-107,1.20E-104,1,0,0,0,0,1
Self-reported allergy.txt,138.1,9.60E-107,5.40E-104,4,5,5,4,6,1
Neutrophil count.txt,137.8,1.30E-106,7.90E-104,6,5,6,6,5,1
Gallbladder cancer.txt,137.8,1.50E-106,8.90E-104,0,0,0,0,0,1
Homocysteine levels.txt,137.3,3.00E-106,1.70E-103,9,10,10,9,9,0
Type 1 diabetes.txt,137.2,3.80E-106,2.10E-103,5,7,6,7,6,1
Progression free survival in metastatic colorectal cancer treatment interaction.txt,136,2.80E-105,1.50E-102,0,1,1,1,1,1
Atrial fibrillation.txt,135.4,7.00E-105,3.90E-102,1,4,3,3,3,1
Serum thyroid-stimulating hormone levels.txt,135.2,9.60E-105,5.40E-102,1,2,2,1,1,1
Hoarding.txt,135.1,1.20E-104,7.00E-102,0,0,0,0,1,1
Waist Circumference - Triglycerides WC-TG.txt,134.9,1.60E-104,9.20E-102,6,6,4,6,4,1
Sexual dysfunction female.txt,134.2,4.90E-104,2.70E-101,2,2,2,2,2,1
IgE levels.txt,133.4,1.80E-103,1.00E-100,1,2,2,2,2,1
Congenital heart malformation.txt,132.9,4.20E-103,2.30E-100,0,1,0,0,0,1
Plasma homocysteine levels post-methionine load test.txt,132,2.00E-102,1.10E-99,1,1,1,1,1,1
Uric acid levels.txt,131.6,4.00E-102,2.20E-99,9,11,10,11,10,0
Sexual dysfunction SSRISNRI-related.txt,131.2,7.20E-102,4.00E-99,1,2,2,2,2,1
Alcohol dependence age at onset.txt,131,9.80E-102,5.40E-99,9,8,8,8,7,1
B-type natriuretic peptide.txt,130.8,1.50E-101,8.30E-99,1,2,1,2,1,1
Cough in response to angiotensin-converting enzyme inhibitor drugs.txt,130.5,2.10E-101,1.20E-98,0,1,0,1,1,1
Renal cell carcinoma.txt,129.6,1.00E-100,5.80E-98,2,1,2,1,2,1
Cerebral amyloid angiopathy.txt,129,2.80E-100,1.50E-97,1,0,0,0,1,1
Plasma homocysteine levels.txt,128.1,1.20E-99,6.60E-97,1,1,1,1,2,1
Coronary restenosis.txt,128,1.40E-99,7.90E-97,1,0,0,1,1,1
Insulin-like growth factors.txt,127.6,2.50E-99,1.30E-96,1,2,2,2,3,1
White blood cell count.txt,127.5,3.10E-99,1.60E-96,8,9,9,9,8,0
Apolipoprotein Levels.txt,127.1,6.20E-99,3.30E-96,1,2,2,2,2,1
Mean corpuscular hemoglobin concentration.txt,126.8,1.00E-98,5.90E-96,3,2,2,2,3,1
Social communication problems.txt,126.1,3.10E-98,1.70E-95,3,2,3,3,4,1
Malaria.txt,125.9,4.30E-98,2.30E-95,4,3,3,4,4,1
Periodontitis DPAL.txt,125.3,1.10E-97,6.20E-95,0,0,0,0,0,1
Substance dependence.txt,125.3,1.20E-97,6.50E-95,1,0,0,0,1,1
Cystic fibrosis-related diabetes.txt,125.1,1.80E-97,9.80E-95,2,1,1,1,2,1
Renal sinus fat.txt,125,2.20E-97,1.10E-94,3,3,3,3,2,1
AIDS.txt,123.5,2.30E-96,1.20E-93,0,0,0,0,1,1
Amyotrophic lateral sclerosis age of onset.txt,122.8,7.90E-96,4.20E-93,1,1,1,1,2,1
Preschool internalizing problems.txt,122.7,9.20E-96,4.90E-93,6,6,6,7,7,1
Methotrexate clearance acute lymphoblastic leukemia.txt,122.6,1.00E-95,5.50E-93,0,0,0,0,1,1
Obesity in adult survivors of childhood cancer exposed to cranial radiation.txt,122.5,1.40E-95,7.50E-93,1,2,2,2,1,1
QT interval.txt,122.2,2.10E-95,1.10E-92,27,28,26,29,28,0
Moyamoya disease.txt,122.2,2.30E-95,1.20E-92,0,0,1,1,1,1
Attention deficit hyperactivity disorder inattention symptoms.txt,121.9,3.60E-95,1.90E-92,12,13,13,13,15,0
LDL cholesterol.txt,121,1.50E-94,8.40E-92,20,26,25,25,26,0
Ulcerative colitis or Crohns disease.txt,120.7,2.60E-94,1.30E-91,2,2,2,2,2,1
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor.txt,120.4,4.30E-94,2.20E-91,4,4,4,4,3,1
Prostate cancer aggressiveness.txt,120.3,4.90E-94,2.60E-91,0,0,0,0,0,1
Body mass index in non-asthmatics.txt,119.4,2.10E-93,1.10E-90,3,2,2,2,3,1
Chronic obstructive pulmonary disease-related biomarkers.txt,119.2,3.10E-93,1.60E-90,3,3,3,4,5,1
Arthritis juvenile idiopathic.txt,118.5,1.00E-92,5.40E-90,0,0,1,0,1,1
Bipolar disorder and schizophrenia.txt,118.3,1.30E-92,7.10E-90,3,3,2,3,2,1
Kidney stones.txt,117.8,3.50E-92,1.80E-89,3,3,3,3,3,1
Idiopathic membranous nephropathy.txt,117.5,5.40E-92,2.80E-89,2,2,2,2,1,1
HIV-associated dementia.txt,117.5,5.60E-92,2.90E-89,3,4,4,4,3,1
Ischemic stroke.txt,117.5,6.00E-92,3.00E-89,3,3,2,2,2,1
Mammographic density non-dense area.txt,117.3,7.30E-92,3.70E-89,4,5,5,5,5,1
Cannabis use initiation.txt,116.9,1.60E-91,8.20E-89,6,5,5,6,6,1
Myeloproliferative neoplasms.txt,116.3,3.90E-91,2.00E-88,0,0,0,0,0,1
Hematocrit.txt,116.3,4.00E-91,2.00E-88,0,0,0,0,0,1
Immune response to anthrax vaccine.txt,115.8,9.80E-91,5.00E-88,0,0,0,0,0,1
Mean corpuscular hemoglobin.txt,115.1,3.20E-90,1.60E-87,4,6,6,6,6,1
Basal cell carcinoma.txt,115,3.40E-90,1.70E-87,2,2,2,2,2,1
Glaucoma.txt,114.9,4.30E-90,2.10E-87,5,4,5,5,6,1
Vitamin B levels in ischemic stroke.txt,114.6,7.30E-90,3.70E-87,0,1,1,0,0,1
Resting heart rate.txt,114.5,7.90E-90,4.00E-87,4,2,2,2,3,1
Head circumference infant.txt,114,1.90E-89,1.00E-86,0,0,0,0,0,1
Alcoholism alcohol dependence factor score.txt,113.9,2.40E-89,1.20E-86,2,2,2,2,2,1
Interstitial lung disease.txt,113.2,7.80E-89,3.90E-86,2,3,4,3,3,1
Sclerosing cholangitis and ulcerative colitis combined.txt,112.7,1.70E-88,8.60E-86,3,2,2,2,2,1
Renal function and chronic kidney disease.txt,112.6,2.20E-88,1.10E-85,0,1,1,0,0,1
Anterior chamber depth.txt,111.7,9.90E-88,4.90E-85,0,1,1,1,0,1
Visceral fat.txt,111.1,2.80E-87,1.40E-84,5,6,5,6,6,1
Blood trace element Se levels.txt,110.7,4.90E-87,2.40E-84,1,1,0,1,0,1
"Multiple cancers lung cancer, gastric cancer, and squamous cell carcinoma.txt",110.3,1.00E-86,5.40E-84,2,2,1,2,1,1
Multiple myeloma and monoclonal gammopathy.txt,110.2,1.10E-86,5.90E-84,1,2,1,2,1,1
MS Multiple sclerosis from AV.txt,110.2,1.20E-86,6.30E-84,38,37,39,35,35,0
Complement C3 and C4 levels.txt,110.1,1.40E-86,7.30E-84,0,0,0,0,0,1
Obesity.txt,109.9,2.10E-86,1.00E-83,12,15,14,15,14,0
Middle childhood and early adolescence aggressive behavior.txt,109.8,2.30E-86,1.10E-83,4,3,3,3,3,1
Chronic hepatitis B infection.txt,109.1,8.20E-86,4.00E-83,4,5,4,4,2,1
Proinsulin levels.txt,108.3,2.80E-85,1.30E-82,2,2,2,2,1,1
Suicide risk.txt,108.3,3.10E-85,1.50E-82,1,2,2,2,2,1
Parent of origin effect on language impairment paternal.txt,108.2,3.80E-85,1.80E-82,2,2,1,2,2,1
Graves disease.txt,108.1,4.10E-85,1.90E-82,0,1,1,1,1,1
Inflammatory bowel disease.txt,108,5.10E-85,2.40E-82,46,49,49,50,47,0
Quantitative traits.txt,107.7,8.50E-85,4.10E-82,4,6,5,5,5,1
Body mass index change over time.txt,107,2.70E-84,1.30E-81,2,3,3,3,3,1
CeD Coeliac disease from AV.txt,106.9,3.30E-84,1.60E-81,38,37,40,38,41,0
Sphingolipid levels.txt,106.2,9.90E-84,4.70E-81,3,3,3,3,3,1
Two-hour glucose challenge.txt,105.9,1.90E-83,9.30E-81,0,0,0,0,0,1
Liver enzyme levels.txt,105.5,3.70E-83,1.70E-80,2,3,2,2,1,1
Cortical thickness.txt,105.2,6.10E-83,2.90E-80,2,1,1,1,1,1
P wave duration.txt,105.1,6.70E-83,3.20E-80,1,1,1,0,1,1
Total bilirubin levels in HIV-1 infection.txt,104.9,9.00E-83,4.20E-80,1,1,1,1,0,1
Coronary artery disease.txt,104.8,1.00E-82,5.10E-80,1,1,1,1,1,1
Phytosterol levels.txt,104.8,1.20E-82,5.90E-80,0,1,0,0,0,1
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia.txt,104.5,1.90E-82,9.20E-80,0,1,1,1,1,1
Inflammatory biomarkers.txt,104.3,2.60E-82,1.20E-79,6,5,5,4,4,1
Adolescent idiopathic scoliosis severe.txt,104.2,3.10E-82,1.40E-79,0,0,0,0,0,1
Atrial fibrillationatrial flutter.txt,103.7,7.50E-82,3.50E-79,1,0,1,1,1,1
Schizophrenia treatment resistant.txt,103.5,1.00E-81,5.00E-79,1,1,2,1,2,1
Percentage gas trapping.txt,103.4,1.30E-81,6.20E-79,7,7,7,7,6,1
Adiposity.txt,103.3,1.40E-81,6.50E-79,2,1,2,1,1,1
Vitiligo.txt,103.2,1.60E-81,7.80E-79,1,2,1,1,0,1
IgE levels in asthmatics D.p. specific.txt,103.1,2.00E-81,9.70E-79,0,1,1,0,0,1
Relative hand skill in reading disability.txt,103,2.60E-81,1.20E-78,0,0,0,1,0,1
Reading or mathematical ability.txt,102.7,4.20E-81,1.90E-78,2,2,2,2,3,1
Asymmetrical dimethylarginine levels.txt,102.3,8.10E-81,3.70E-78,0,1,1,1,0,1
Non-alcoholic fatty liver disease histology lobular.txt,102.2,1.00E-80,4.60E-78,2,2,2,2,2,1
Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid.txt,102.2,1.00E-80,4.80E-78,6,6,5,6,6,1
Kawasaki disease.txt,102,1.30E-80,6.20E-78,4,5,4,5,4,1
Pediatric bone mineral content radius.txt,101.9,1.50E-80,7.10E-78,1,1,0,1,0,1
Iron status biomarkers ferritin levels.txt,101.6,2.70E-80,1.20E-77,1,2,2,2,1,1
Forced expiratory volume in 1 second.txt,100.6,1.40E-79,6.60E-77,3,3,3,3,4,1
Alzheimers disease in APOE e4+ carriers.txt,100.6,1.60E-79,7.50E-77,7,6,6,6,6,1
Nasopharyngeal carcinoma.txt,100.2,3.10E-79,1.40E-76,0,0,0,0,0,1
Intraocular pressure.txt,99.9,5.00E-79,2.20E-76,33,33,33,32,31,0
D-dimer levels.txt,99.3,1.50E-78,6.80E-76,1,0,0,1,1,1
Ovarian cancer.txt,99.2,1.70E-78,7.90E-76,2,2,2,2,2,1
Neuroblastoma.txt,98.5,5.10E-78,2.30E-75,5,4,4,4,5,1
Glioma.txt,98.5,5.70E-78,2.50E-75,1,2,2,2,2,1
LDL peak particle diameter total fat intake interaction.txt,98.5,5.90E-78,2.60E-75,9,10,10,10,11,0
Antibody level in response to infection.txt,97.2,5.50E-77,2.40E-74,2,1,1,1,1,1
Colorectal cancer calcium intake interaction.txt,97,7.40E-77,3.20E-74,1,1,1,1,1,1
Meningioma.txt,96.3,2.30E-76,1.00E-73,2,1,2,2,2,1
Testosterone levels.txt,96.3,2.40E-76,1.00E-73,3,2,1,1,1,1
Retinal vascular caliber.txt,96.1,3.30E-76,1.40E-73,0,1,0,0,0,1
Lewy body disease.txt,96,4.50E-76,1.90E-73,1,2,1,2,3,1
Circulating cell-free DNA.txt,94.9,2.50E-75,1.10E-72,1,1,1,1,0,1
Classic bladder exstrophy.txt,94.9,2.60E-75,1.10E-72,0,0,0,1,1,1
Red wine liking.txt,94.5,5.10E-75,2.20E-72,0,0,0,0,0,1
Alzheimers disease biomarkers.txt,94.1,1.00E-74,4.70E-72,3,2,2,2,3,1
Migraine without aura.txt,93.5,3.20E-74,1.40E-71,4,3,3,4,4,1
Biomedical quantitative traits.txt,92.8,1.00E-73,4.40E-71,2,1,1,1,2,1
Type 2 diabetes and other traits.txt,92.5,1.60E-73,7.30E-71,0,1,0,1,0,1
Longevity.txt,92,3.90E-73,1.70E-70,4,3,3,4,4,1
Osteoprotegerin levels.txt,91.7,6.70E-73,2.90E-70,5,4,4,4,5,1
Lipid traits.txt,91.5,1.00E-72,4.30E-70,9,9,8,8,7,1
Mammographic density.txt,90.9,2.60E-72,1.10E-69,2,1,1,1,2,1
PR segment.txt,90.6,4.60E-72,1.90E-69,3,3,3,3,3,1
Serum uric acid levels.txt,90.6,5.00E-72,2.10E-69,3,2,2,2,2,1
Fasting glucose-related traits.txt,90.5,5.20E-72,2.20E-69,11,8,8,9,9,0
Sleep duration.txt,90.3,7.50E-72,3.20E-69,0,0,1,1,1,1
Multiple myeloma hyperdiploidy.txt,90.3,7.70E-72,3.20E-69,2,2,3,3,2,1
Angiotensin-converting enzyme activity.txt,90.2,9.50E-72,4.00E-69,0,0,0,0,0,1
Hippocampal sclerosis.txt,90.1,1.10E-71,4.80E-69,2,2,2,2,2,1
Fuchss corneal dystrophy.txt,90.1,1.20E-71,5.10E-69,0,0,0,0,0,1
Osteosarcoma.txt,89.9,1.60E-71,7.00E-69,2,2,2,2,2,1
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined.txt",89.6,2.40E-71,1.00E-68,17,17,17,17,14,0
Cardiovascular disease risk factors.txt,89.5,3.30E-71,1.30E-68,1,2,1,2,1,1
Cutaneous nevi.txt,89.2,5.00E-71,2.00E-68,1,2,1,2,1,1
Blood pressure measurement high sodium and potassium intervention.txt,88.8,1.10E-70,4.50E-68,1,0,0,0,0,1
Plasma amyloid beta peptide concentrations ABx-42.txt,88.2,3.00E-70,1.20E-67,1,1,1,1,1,1
Airway imaging phenotypes.txt,88.1,3.40E-70,1.40E-67,5,4,4,4,4,1
Gambling.txt,88.1,3.70E-70,1.50E-67,3,3,3,3,3,1
Weight loss gastric bypass surgery.txt,87.6,9.40E-70,3.80E-67,0,0,0,0,0,1
Bipolar disorder.txt,87.5,1.00E-69,4.30E-67,17,16,15,16,16,0
Lung adenocarcinoma.txt,87.4,1.20E-69,5.20E-67,0,0,0,0,1,1
Hypertension.txt,87.2,1.90E-69,7.80E-67,16,14,14,14,13,0
Neuropathic pain in type 2 diabetes.txt,87.2,1.90E-69,7.70E-67,2,2,2,3,2,1
Kidney function decline traits.txt,86.1,1.10E-68,4.80E-66,3,2,3,4,2,1
Hippocampal atrophy.txt,85.3,5.30E-68,2.10E-65,3,6,4,5,4,1
Protein C levels.txt,84.1,3.90E-67,1.60E-64,0,1,1,0,1,1
Airway hyperresponsiveness.txt,84,5.00E-67,2.00E-64,0,1,1,1,1,1
Folate pathway vitamin levels.txt,83.9,5.70E-67,2.30E-64,4,4,4,4,4,1
Caffeine consumption.txt,83.8,6.30E-67,2.50E-64,5,4,4,5,4,1
Urinary metabolites.txt,83.4,1.30E-66,5.20E-64,0,0,0,0,0,1
Change in intraocular pressure in response to steroid treatment triamcinolone acetonide.txt,83.1,2.20E-66,8.80E-64,1,1,1,1,1,1
Osteoarthritis hip.txt,83,2.50E-66,1.00E-63,1,1,1,1,0,1
Lupus nephritis in systemic lupus erythematosus.txt,82.4,8.40E-66,3.30E-63,1,2,2,1,1,1
Liver enzyme levels alanine transaminase.txt,82.1,1.30E-65,5.30E-63,2,3,4,4,3,1
Vogt-Koyanagi-Harada syndrome.txt,82,1.70E-65,6.70E-63,0,0,0,0,0,1
Dietary macronutrient intake.txt,81.9,1.90E-65,7.50E-63,4,4,3,3,3,1
Autism.txt,81.7,2.60E-65,1.00E-62,2,2,2,2,3,1
Systemic lupus erythematosus.txt,81.3,5.20E-65,2.00E-62,22,24,24,22,22,0
RR interval heart rate.txt,81.2,6.40E-65,2.50E-62,6,4,6,5,6,1
Cholesterol and Triglycerides.txt,80.8,1.30E-64,5.30E-62,1,1,1,1,2,1
Ossification of the posterior longitudinal ligament of the spine.txt,80.3,3.10E-64,1.20E-61,0,0,0,0,1,1
Gastric cancer.txt,80.3,3.30E-64,1.20E-61,0,0,0,0,0,1
Natriuretic peptide levels.txt,79.9,6.60E-64,2.50E-61,1,0,0,1,0,1
Glaucoma exfoliation.txt,78.9,3.70E-63,1.40E-60,1,2,2,2,2,1
Gout.txt,78.7,5.20E-63,2.00E-60,6,4,5,5,4,1
Iron levels.txt,78.3,9.90E-63,3.80E-60,2,1,1,1,1,1
Serum dimethylarginine levels asymmetric_symetric ratio.txt,78.3,1.00E-62,4.10E-60,2,1,1,0,1.5,1
Celiac disease.txt,78,1.70E-62,6.80E-60,3,4,3,3,2,1
Fasting plasma glucose.txt,78,1.70E-62,6.50E-60,0,0,0,0,0,1
Central corneal thickness.txt,77.8,2.40E-62,9.40E-60,3,4,4,4,4,1
Smoking behavior.txt,77.5,4.60E-62,1.70E-59,3,4,4,4,4,1
Pit-and-Fissure caries.txt,77.2,6.90E-62,2.60E-59,10,10,10,10,10,0
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy.txt,77.2,7.00E-62,2.60E-59,1,1,1,1,1,1
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.txt,76.4,3.20E-61,1.20E-58,1,1,0,0,0,1
Asthma.txt,76,6.60E-61,2.50E-58,2,3,3,2,3,1
Alcoholism heaviness of drinking.txt,75.5,1.60E-60,6.00E-58,2,2,2,2,2,1
Glomerular filtration rate.txt,75.3,2.20E-60,8.20E-58,2,2,2,2,3,1
Formal thought disorder in schizophrenia.txt,75.1,2.90E-60,1.10E-57,0,0,0,0,0,1
PR interval.txt,74.4,1.00E-59,3.80E-57,11,11,11,11,13,0
Underweight status.txt,74.2,1.50E-59,5.70E-57,2,2,2,2,2,1
Breast cancer.txt,74.2,1.60E-59,6.00E-57,23,20,19,19,21,0
Height adjusted BMI.txt,74.2,1.60E-59,5.90E-57,0,1,0,1,0,1
Crohns disease.txt,74.1,1.80E-59,6.90E-57,50,55,53,51,45,0
Colorectal cancer.txt,74.1,1.90E-59,6.90E-57,16,16,15,15,15,0
Heschls gyrus morphology.txt,73.7,3.90E-59,1.40E-56,19,19,20,21,21,0
Butyrylcholinesterase levels.txt,73.6,4.10E-59,1.50E-56,2,1,1,1,1,1
Chronic obstructive pulmonary disease.txt,73.6,4.20E-59,1.50E-56,5,4,4,4,4,1
Attention function in attention deficit hyperactive disorder.txt,73.5,5.50E-59,1.90E-56,15,13,14,13,12,0
Brain structure hippocampal volume.txt,73.1,1.00E-58,3.80E-56,1,1,2,2,1,1
Osteoarthritis biomarkers.txt,73.1,1.10E-58,4.00E-56,0,0,0,0,0,1
Post-traumatic stress disorder.txt,72.9,1.60E-58,5.90E-56,0,2,2,2,0,1
Urinary uromodulin levels.txt,72.5,3.00E-58,1.10E-55,2,2,2,2,3,1
Vascular brain injury.txt,72.5,3.00E-58,1.00E-55,1,2,2,2,0,1
Chronic obstructive pulmonary disease moderate to severe.txt,71.5,1.80E-57,6.60E-55,2,2,2,1,2,1
Amyotrophic lateral sclerosis sporadic.txt,71.3,2.50E-57,8.90E-55,1,1,2,1,1,1
Lifetime average cigarettes per day in chronic obstructive pulmonary disease.txt,71.2,3.10E-57,1.10E-54,3,3,2,2,2,1
Optic nerve measurement cup area.txt,71.1,3.50E-57,1.20E-54,2,3,2,2,2,1
Parkinsons disease age of onset.txt,71,4.40E-57,1.50E-54,1,1,1,1,1,1
Peripheral artery disease.txt,71,4.80E-57,1.60E-54,0,0,0,0,0,1
Schizophrenia cytomegalovirus infection interaction.txt,70.9,5.30E-57,1.80E-54,1,0,1,0,1,1
Allergic dermatitis nickel.txt,70.6,8.70E-57,3.00E-54,1,1,1,1,1,1
Hearing function.txt,70.5,1.00E-56,3.80E-54,5,4,4,4,4,1
Soluble levels of adhesion molecules.txt,70.5,1.00E-56,3.70E-54,5,6,6,6,5,1
Glycated hemoglobin levels.txt,70.5,1.10E-56,4.10E-54,2,2,3,2,4,1
SS Systemic sclerosis from AV.txt,70.4,1.20E-56,4.20E-54,0,1,1,1,1,1
Systolic blood pressure alcohol consumption interaction.txt,70.3,1.60E-56,5.60E-54,2,2,2,2,2,1
Digestive system disease Barretts esophagus and esophageal adenocarcinoma combined.txt,70.1,2.10E-56,7.20E-54,1,2,1,2,2,1
Urinary albumin excretion rate in type 1 diabetes.txt,69.8,3.90E-56,1.30E-53,0,0,0,0,1,1
Alopecia areata.txt,69.7,4.90E-56,1.60E-53,2,1,1,2,2,1
Weight.txt,69.5,7.20E-56,2.40E-53,5,6,5,5,4,1
Temperament.txt,69.4,7.30E-56,2.40E-53,5,5,5,6,6,1
Hepatocellular carcinoma hepatitis B virus related.txt,69.4,8.50E-56,2.80E-53,2,2,2,2,2,1
IgE levels in asthmatics D.f. specific.txt,69.3,9.40E-56,3.10E-53,3,2,2,3,2,1
Breast size.txt,69.1,1.40E-55,4.70E-53,4,3,4,3,4,1
Other erythrocyte phenotypes.txt,69,1.50E-55,5.00E-53,0,1,1,0,1,1
Bulimia nervosa.txt,69,1.60E-55,5.40E-53,10,9,9,9,10,0
Dementia and core Alzheimers disease neuropathologic changes.txt,69,1.60E-55,5.60E-53,6,4,4,4,4,1
Urate levels in lean individuals.txt,68.7,2.70E-55,9.10E-53,4,3,4,4,3,1
Age-related nuclear cataracts.txt,68.2,6.50E-55,2.10E-52,0,0,0,0,0,1
Parkinson disease and lewy body pathology.txt,68.2,7.20E-55,2.30E-52,0,0,0,0,0,1
Carotid intima media thickness.txt,68.1,7.90E-55,2.60E-52,3,2,1,1,1,1
Hippocampal sclerosis of aging.txt,67.8,1.30E-54,4.50E-52,1,1,1,1,1,1
Iron status biomarkers transferrin levels.txt,67.4,2.70E-54,9.00E-52,3,4,5,4,5,1
"Fibrinogen levels smoking status, alcohol consumption or body mass index interaction.txt",67.2,4.40E-54,1.40E-51,2,1,2,2,2,1
Cerebrospinal AB1-42 levels in Alzheimers disease dementia.txt,66.9,7.30E-54,2.30E-51,0,0,0,0,0,1
Hodgkins lymphoma.txt,66.8,9.10E-54,2.90E-51,0,0,0,0,0,1
Non-alcoholic fatty liver disease.txt,66.5,1.40E-53,4.70E-51,0,0,0,0,0,1
Carotid artery intima media thickness sex interaction.txt,66.1,3.10E-53,1.00E-50,0,1,1,1,2,1
Asthma toluene diisocyanate-induced.txt,65.8,5.30E-53,1.70E-50,2,2,1,1,1,1
Blood metabolite levels.txt,65.2,1.30E-52,4.40E-50,98,94,94,98,97,0
Keloid.txt,65,1.90E-52,6.20E-50,0,0,0,0,0,1
Brain structure temporal lobe volume.txt,65,2.00E-52,6.50E-50,3,3,3,3,3,1
Bone mineral density paediatric total body less head.txt,64.6,4.00E-52,1.20E-49,5,4,4,4,4,1
Body mass index.txt,64.2,9.30E-52,2.90E-49,83,86,82,84,82,0
Puberty onset genital enlargement.txt,63.8,1.70E-51,5.50E-49,1,1,2,1,1,1
Melanoma.txt,63.6,2.40E-51,7.70E-49,3,3,3,3,4,1
Thyroid function.txt,63.3,4.40E-51,1.30E-48,1,1,1,1,2,1
Plasma omega-6 polyunsaturated fatty acid levels adrenic acid.txt,61.8,6.20E-50,1.90E-47,1,1,1,1,1,1
Breast Cancer in BRCA1 mutation carriers.txt,61.5,1.00E-49,3.40E-47,4,2,3,3,2,1
Triglycerides-Blood Pressure TG-BP.txt,60.4,9.20E-49,2.80E-46,0,1,1,0,0,1
Hemoglobin.txt,60.3,1.00E-48,3.30E-46,3,3,3,4,4,1
Renal transplant outcome.txt,60.3,1.10E-48,3.40E-46,0,0,0,0,0,1
Body mass index age interaction.txt,60.1,1.40E-48,4.40E-46,1,1,1,1,1,1
DNA methylation variation.txt,59.6,3.50E-48,1.00E-45,4,3,3,3,3,1
Orthostatic hypotension.txt,59.6,3.70E-48,1.10E-45,0,0,0,0,0,1
C-reactive protein.txt,59.3,5.70E-48,1.70E-45,5,6,7,7,8,1
Dupuytrens disease.txt,59.1,8.80E-48,2.60E-45,1,1,1,1,0.5,1
Sitting height ratio.txt,58.9,1.30E-47,3.90E-45,14,13,14,14,12,0
Brain connectivity.txt,58.6,2.10E-47,6.50E-45,0,1,0,1,1,1
Prothrombin time.txt,58.6,2.10E-47,6.40E-45,2,2,2,2,2,1
Fat body mass.txt,58.5,2.50E-47,7.50E-45,0,1,1,1,1,1
Alloimmunization response to red blood cell transfusion in sickle cell anemia.txt,58.4,3.40E-47,1.00E-44,0,0,0,0,0,1
Carotenoid and tocopherol levels.txt,58.4,3.40E-47,1.00E-44,0,0,0,0,0,1
C-reactive protein and white blood cell count.txt,57.8,9.20E-47,2.70E-44,2,2,2,2,2,1
Cardia gastric cancer.txt,57.7,1.00E-46,3.20E-44,1,2,2,1,1,1
Pubertal anthropometrics.txt,57.5,1.60E-46,4.70E-44,14,12,12,13,13,0
Insomnia caffeine-induced.txt,57,3.80E-46,1.10E-43,0,0,0,0,0,1
Myopia severe.txt,56.7,6.40E-46,1.80E-43,0,1,1,1,0,1
Suicide attempts in bipolar disorder.txt,56.7,6.90E-46,2.00E-43,0,0,1,1,0,1
Cotinine glucuronidation.txt,56.3,1.40E-45,4.10E-43,4,5,5,5,4,1
Circulating vasoactive peptide levels.txt,55.6,5.40E-45,1.50E-42,1,0,0,0,1,1
Type 1 diabetes autoantibodies.txt,55.5,5.70E-45,1.60E-42,4,5,4,4,3,1
Squamous cell carcinoma.txt,55.5,5.80E-45,1.60E-42,2,2,2,2,2,1
Narcolepsy with cataplexy.txt,55.4,7.50E-45,2.10E-42,0,0,0,0,0,1
Disc degeneration lumbar.txt,55.4,7.60E-45,2.10E-42,15,14,14,15,14,0
Glaucoma primary open-angle.txt,55.3,8.40E-45,2.30E-42,5,3,4,4,4,1
Major depressive disorder.txt,55,1.40E-44,4.00E-42,9,9,9,9,9,0
Coronary spasm.txt,55,1.50E-44,4.40E-42,2,2,2,2,2,1
Height.txt,55,1.50E-44,4.20E-42,232,246,243,245,242,0
Infantile hypertrophic pyloric stenosis.txt,54.8,2.30E-44,6.50E-42,2,2,2,2,2,1
HIV-1 progression.txt,54.7,2.40E-44,6.80E-42,1,1,1,2,2,1
Nonalcoholic fatty liver disease.txt,54.1,7.40E-44,2.00E-41,3,3,3,3,3,1
Cardiovascular heart disease in diabetics.txt,54,1.00E-43,2.80E-41,1,1,1,1,2,1
Coffee consumption cups per day.txt,53.9,1.10E-43,3.20E-41,4,4,3,4,3,1
Depression quantitative trait.txt,53.7,1.70E-43,4.80E-41,7,7,7,7,8,bod
Airflow obstruction.txt,53.3,3.20E-43,8.70E-41,4,3,3,4,4,1
Fasting insulin-related traits.txt,53.2,4.00E-43,1.10E-40,1,2,2,2,1,1
Amino acid levels.txt,53.2,4.10E-43,1.10E-40,3,2,2,2,2,1
Protein biomarker.txt,53.1,5.00E-43,1.30E-40,1,1,0,1,0,1
Sasang constitutional medicine type So-Eum.txt,53,5.50E-43,1.50E-40,1,1,2,1,2,1
Red blood cell fatty acid levels.txt,53,5.60E-43,1.50E-40,1,1,1,2,2,1
Subcutaneous adipose tissue.txt,52.1,3.10E-42,8.30E-40,15,16,15,15,13,0
Systemic sclerosis.txt,51.9,4.00E-42,1.00E-39,1,0,1,0,1,1
Cerebrospinal P-tau181p levels.txt,51.7,5.80E-42,1.50E-39,1,1,1,0,0,1
Cervical cancer.txt,51.7,5.80E-42,1.50E-39,3,3,3,3,2,1
Metabolic syndrome bivariate traits.txt,51.4,1.10E-41,3.10E-39,1,1,1,0,0,1
Resting oxygen saturation in chronic osbtructive pulmonary disease pulse oxymetry.txt,51.2,1.50E-41,3.90E-39,1,1,1,1,1,1
Attention deficit hyperactivity disorder.txt,51.1,1.70E-41,4.60E-39,2,2,2,2,3,1
AS Ankylosing spondylitis from AV.txt,51.1,2.00E-41,5.20E-39,28,27,28,30,29,0
Lp a levels.txt,51,2.10E-41,5.50E-39,1,1,1,1,1,1
PS Psoriasis from AV.txt,50.9,2.50E-41,6.40E-39,32,30,32,33,31,0
Phospholipid levels plasma.txt,50.9,2.50E-41,6.60E-39,13,14,13,13,13,0
Multiple myeloma.txt,50.9,2.80E-41,7.30E-39,4,5,4,6,4,1
Alcoholism 12-month weekly alcohol consumption.txt,50.8,3.00E-41,7.70E-39,2,2,2,2,2,1
Small-cell lung cancer survival.txt,50.7,3.90E-41,9.90E-39,1,1,1,1,0,1
Smoking cessation in chronic obstructive pulmonary disease.txt,50.1,1.10E-40,2.90E-38,0,0,0,0,0,1
Insulin-related traits.txt,50,1.30E-40,3.30E-38,1,1,0,0,0,1
Cardiac structure and function.txt,49.9,1.50E-40,3.90E-38,0,0,0,0,0,1
Polycystic ovary syndrome.txt,50,1.50E-40,3.80E-38,8,7,8,8,8,1
Anorexia nervosa.txt,49.7,2.30E-40,5.80E-38,8,8,8,8,7,1
Vitamin D levels.txt,49.6,3.10E-40,7.70E-38,5,5,6,6,5,1
Spontaneous preterm birth preterm birth.txt,49.1,7.70E-40,1.90E-37,0,1,0,1,0,1
Toenail selenium levels.txt,48.7,1.40E-39,3.60E-37,6,6,5,6,6,1
Hematological parameters.txt,48.5,2.30E-39,5.70E-37,0,1,0,0,0,1
Anxiety in major depressive disorder.txt,48.4,2.50E-39,6.20E-37,1,1,1,1,1,1
Hepatitis.txt,48.4,2.50E-39,6.20E-37,2,2,2,2,2,1
Pneumoconiosis in silica exposure.txt,48,6.00E-39,1.40E-36,0,0,0,1,0,1
Visceral adipose tissue adjusted for BMI.txt,47.4,1.60E-38,3.90E-36,9,7,7,7,8,1
Attention deficit hyperactivity disorder symptoms interaction.txt,47.1,2.70E-38,6.50E-36,1,1,1,1,1,1
Urinary bladder cancer.txt,47,3.50E-38,8.60E-36,0,0,0,0,1,1
Waist-hip ratio.txt,46.7,5.70E-38,1.30E-35,5,5,5,5,5,1
Superior frontal gyrus grey matter volume.txt,46.6,7.50E-38,1.70E-35,3,4,3,3,3,1
Mean corpuscular volume.txt,46.4,1.00E-37,2.40E-35,6,8,7,8,9,1
JIA Juvenile idiopathic arthritis from AV.txt,46.3,1.30E-37,3.10E-35,13,12,12,12,11,0
Non-substance related behavioral disinhibition.txt,46.2,1.60E-37,3.80E-35,2,1,2,2,2,1
Mammographic density dense area.txt,46,2.00E-37,4.70E-35,10,8,8,9,10,0
Motion sickness.txt,45.8,3.10E-37,7.40E-35,12,12,12,11,12,0
Renal function-related traits eGRFcrea.txt,45.5,5.40E-37,1.20E-34,1,2,1,1,1,1
Gamma gluatamyl transferase levels.txt,45.3,7.40E-37,1.70E-34,0,0,0,0,0,1
Reading and spelling.txt,45.3,7.40E-37,1.70E-34,4,5,4,5,5,1
Longitudinal alcohol consumption.txt,45.3,7.50E-37,1.70E-34,4,5,5,5,5,1
Multiple sclerosis.txt,45.3,7.70E-37,1.70E-34,24,27,26,28,26,0
Vaspin levels.txt,45.1,1.20E-36,2.70E-34,2,1,1,1,2,1
Blood metabolite ratios.txt,45,1.50E-36,3.40E-34,26,23,22,23,21,0
Puberty onset.txt,44.7,2.40E-36,5.40E-34,0,0,0,0,0,1
PCA3 expression level.txt,44.5,3.60E-36,8.10E-34,1,1,1,1,0,1
Body mass index interaction.txt,44.4,4.20E-36,9.40E-34,2,2,2,1,2,1
HDL cholesterol.txt,44.4,4.30E-36,9.50E-34,43,42,41,43,41,0
Primary biliary cirrhosis.txt,44.1,7.40E-36,1.60E-33,8,7,8,7,8,1
Chronic hepatitis C infection.txt,44,8.10E-36,1.70E-33,0,0,0,0,0,1
Biliary atresia.txt,44,8.30E-36,1.80E-33,0,1,0,1,0,1
Periodontitis.txt,43.8,1.20E-35,2.60E-33,1,1,1,1,1,1
Waist circumference and related phenotypes.txt,43.8,1.20E-35,2.60E-33,0,0,0,1,0,1
Verbal declarative memory.txt,43.5,2.20E-35,4.80E-33,6,6,5,6,5,1
Lung cancer.txt,43.3,3.30E-35,7.10E-33,4,3,3,3,4,1
Diabetic retinopathy.txt,42.7,1.00E-34,2.20E-32,6,5,5,5,6,1
Nonsyndromic cleft lip with or without cleft palate.txt,42.6,1.20E-34,2.60E-32,0,0,0,0,1,1
White matter integrity.txt,42.3,2.00E-34,4.30E-32,1,1,1,0,1,1
Osteoporosis-related phenotypes.txt,42.3,2.20E-34,4.60E-32,1,1,1,1,1,1
Insulin resistance response.txt,42.1,2.90E-34,6.00E-32,1,1,1,1,2,1
Sickle cell anemia haemolysis.txt,41.9,4.50E-34,9.40E-32,1,1,1,1,0,1
Osteoporosis.txt,41.8,5.10E-34,1.00E-31,1,1,1,1,1,1
Sleep time.txt,41.7,5.70E-34,1.10E-31,0,0,0,0,0,1
Axial length.txt,41.1,1.90E-33,4.00E-31,5,5,6,6,7,1
Psoriasis.txt,41,2.20E-33,4.60E-31,20,24,25,24,24,0
Cerebrospinal T-tau levels.txt,41,2.30E-33,4.70E-31,0,1,1,1,1,1
Common traits Other.txt,41,2.30E-33,4.60E-31,0,0,0,0,0,1
Birth length.txt,40.9,2.70E-33,5.40E-31,3,2,2,2,3,1
Age-related cataracts age at onset.txt,40,1.40E-32,2.80E-30,2,2,2,2,2,1
Symmetrical dimethylarginine levels.txt,40,1.50E-32,3.00E-30,2,2,2,2,2,1
Aortic root size.txt,39.7,2.50E-32,5.00E-30,0,1,1,1,0,1
Narcolepsy.txt,39.6,3.20E-32,6.30E-30,3,2,3,3,2,1
Cytomegalovirus antibody response.txt,39.4,4.70E-32,9.20E-30,2,1,1,2,1,1
Ovarian cancer in BRCA1 mutation carriers.txt,39.3,5.30E-32,1.00E-29,1,0,1,0,1,1
Hemostatic factors and hematological phenotypes.txt,39.2,6.50E-32,1.20E-29,2,1,1,1,1,1
Paclitaxel-induced neuropathy.txt,39.1,7.90E-32,1.50E-29,0,0,0,0,0,1
Retinopathy in non-diabetics.txt,39,1.00E-31,1.90E-29,7,7,7,7,7,1
Intelligence childhood.txt,38.7,1.60E-31,3.10E-29,2,1,1,1,1,1
Periodontitis CDC AAP.txt,38.4,2.80E-31,5.30E-29,7,6,6,6,5,1
B cell non-Hodgkin lymphoma.txt,37.9,6.90E-31,1.30E-28,1,0,0,0,0,1
Tourette syndrome.txt,37.9,6.90E-31,1.30E-28,1,1,1,1,0,1
Asthma and hay fever.txt,37.9,7.70E-31,1.40E-28,2,2,2,2,2,1
Allergic rhinitis.txt,37.8,7.90E-31,1.40E-28,3,3,3,3,2,1
Bronchopulmonary dysplasia.txt,37.8,7.90E-31,1.40E-28,4,4,5,4,4,1
Blood pressure.txt,37.7,1.10E-30,2.00E-28,3,4,4,4,5,1
N-glycan levels.txt,37.7,1.10E-30,2.00E-28,3,1,1,2,2,1
Urate levels in obese individuals.txt,37.7,1.10E-30,2.00E-28,3,4,4,3,3,1
Carotid plaque burden smoking interaction.txt,37.5,1.60E-30,2.90E-28,0,1,1,1,1,1
Optic nerve measurement disc area.txt,37.2,2.40E-30,4.40E-28,6,7,6,6,7,1
Alzheimers disease.txt,37.2,2.50E-30,4.50E-28,4,4,4,4,4,1
Acne severe.txt,37,4.10E-30,7.40E-28,2,2,2,2,2,1
Beta-2 microglubulin plasma levels.txt,36.5,9.00E-30,1.50E-27,2,2,2,2,1,1
Non-cardia gastric cancer.txt,36.5,1.00E-29,1.70E-27,1,2,2,1,1,1
Serum albumin level.txt,36.5,1.00E-29,1.70E-27,1,1,1,1,1,1
Chronic mucus hypersecretion.txt,36.4,1.10E-29,1.90E-27,1,1,1,0,1,1
F-cell distribution.txt,36.4,1.20E-29,2.20E-27,0,0,0,0,0,1
Anthropometric traits in newborns.txt,36,2.40E-29,4.10E-27,2,2,2,2,2,1
Testicular germ cell tumor.txt,35.8,3.90E-29,6.60E-27,7,5,5,5,5,1
HIV-1 control.txt,35.5,6.20E-29,1.00E-26,0,0,0,0,0,1
Amyloid A serum levels.txt,35.5,6.90E-29,1.10E-26,1,1,1,1,1,1
Pagets disease.txt,35.2,1.10E-28,1.80E-26,1,2,2,2,4,1
Red blood cell count.txt,35.1,1.40E-28,2.30E-26,1,1,1,1,1,1
Serum alpha1-antitrypsin levels.txt,35,1.60E-28,2.80E-26,0,0,0,0,0,1
Parkinsons disease.txt,34.8,2.50E-28,4.10E-26,14,18,17,18,19,0
Hemoglobin levels.txt,34.7,2.90E-28,4.70E-26,0,0,0,0,0,1
Speech perception in dyslexia.txt,34.7,3.00E-28,4.90E-26,0,0,0,0,0,1
Facial pigmentation.txt,34.2,7.00E-28,1.10E-25,0,0,0,0,0,1
Hearing impairment.txt,34.1,9.20E-28,1.40E-25,2,2,2,2,2,1
Mitral valve prolapse.txt,33.9,1.20E-27,1.90E-25,2,2,2,2,2,1
Alcohol dependence.txt,33.8,1.60E-27,2.60E-25,2,1,1,1,1,1
Puberty onset breast development.txt,33.7,1.90E-27,3.10E-25,1,1,1,1,1,1
Systolic blood pressure.txt,33.3,4.10E-27,6.40E-25,11,11,11,10,11,0
Uterine fibroids.txt,32.5,1.70E-26,2.70E-24,1,0,0,0,0,1
UC Ulcerative colitis from AV.txt,32.4,1.90E-26,2.90E-24,25,23,23,24,24,0
Corneal structure.txt,32.1,3.50E-26,5.40E-24,10,10,10,9,9,0
Obstructive sleep apnea.txt,32.1,3.80E-26,5.80E-24,1,1,1,1,2,1
Diabetic retinopathy in type 2 diabetes.txt,32,4.10E-26,6.20E-24,1,1,1,1,1,1
Hypertriglyceridemia.txt,31.9,5.10E-26,7.70E-24,0,1,1,0,1,1
Febrile seizures MMR vaccine-unrelated.txt,31.8,6.10E-26,9.20E-24,0,0,0,0,0,1
Tetralogy of Fallot.txt,31.6,9.50E-26,1.40E-23,1,1,1,1,1,1
ATD Autoimmune thyroid disease from AV.txt,31.5,1.10E-25,1.70E-23,2,2,2,3,2,1
Aging time to death.txt,31.1,2.40E-25,3.60E-23,2,3,3,3,3,1
Metabolic traits.txt,31.1,2.50E-25,3.70E-23,7,7,6,8,7,1
Alcohol consumption.txt,31,2.80E-25,4.00E-23,1,0,1,1,1,1
Cerebrospinal fluid levels of Alzheimers disease-related proteins.txt,30.9,3.30E-25,4.80E-23,1,1,1,0,1,1
Major depressive disorder broad.txt,30.9,3.30E-25,4.80E-23,3,3,3,3,3,1
Stroke.txt,30.8,4.30E-25,6.20E-23,4,6,5,5,5,1
Disease-free survival in breast cancer.txt,30.8,4.40E-25,6.30E-23,0,0,1,0,0,1
White blood cell types.txt,30.6,6.30E-25,8.90E-23,4,4,4,4,4,1
Cervical artery dissection.txt,30.5,6.80E-25,9.40E-23,3,2,2,2,1,1
Body mass lean.txt,30.5,7.50E-25,1.00E-22,0,0,0,0,0,1
Opioid sensitivity.txt,30.1,1.40E-24,1.90E-22,0,1,1,1,1,1
Chronic lymphocytic leukemia.txt,30,1.90E-24,2.70E-22,7,9,8,8,7,1
Barretts esophagus.txt,29.8,2.50E-24,3.40E-22,3,3,3,4,4,1
Venous thromboembolism.txt,29.7,3.30E-24,4.40E-22,4,4,4,4,5,1
Anger.txt,29.5,5.00E-24,6.60E-22,2,3,4,4,3,1
Non-alcoholic fatty liver disease histology AST.txt,29.4,5.50E-24,7.20E-22,0,0,0,0,0,1
Testicular germ cell cancer.txt,29,1.10E-23,1.50E-21,1,1,1,1,1,1
Allergic rhinitis in non-asthmatics.txt,28.8,1.90E-23,2.50E-21,2,2,1,2,1,1
Behavioural disinhibition generation interaction.txt,28.7,2.30E-23,2.90E-21,2,2,2,2,3,1
Coagulation factor levels.txt,28.4,3.40E-23,4.40E-21,0,0,0,0,0,1
Food antigen IgG levels.txt,28,8.40E-23,1.00E-20,1,1,1,1,1,1
Metabolic syndrome.txt,27.8,1.10E-22,1.40E-20,6,6,6,6,6,1
Corneal curvature.txt,27.7,1.40E-22,1.80E-20,5,8,7,7,6,1
PSCh Primary sclerosing cholangitis from AV.txt,27.7,1.50E-22,1.80E-20,7,8,7,7,7,1
Osteoarthritis.txt,27.6,1.70E-22,2.10E-20,2,3,3,2,3,1
Hepatocellular carcinoma.txt,27.5,1.90E-22,2.40E-20,4,3,3,3,3,1
Pancreatic cancer.txt,27.5,1.90E-22,2.30E-20,13,12,12,14,11,0
HIV-1 viral setpoint.txt,27.5,2.10E-22,2.50E-20,2,4,3,3,3,1
Postprandial triglyceride response to high fat diet meal.txt,27.4,2.40E-22,2.80E-20,2,3,3,3,2,1
Migraine.txt,27.3,3.10E-22,3.70E-20,5,7,6,7,6,1
Type 1 diabetes nephropathy.txt,27.3,3.20E-22,3.70E-20,4,5,5,5,5,1
Renal function-related traits sCR.txt,27.1,4.40E-22,5.10E-20,1,2,1,1,1,1
Sex hormone-binding globulin levels.txt,27,5.40E-22,6.30E-20,4,5,5,6,5,1
Intracranial volume.txt,26.8,8.40E-22,9.60E-20,1,1,1,1,1,1
Refractive error.txt,26.7,9.00E-22,1.00E-19,4,4,3,5,4,1
Hip bone size.txt,26.6,1.10E-21,1.20E-19,2,2,2,2,2,1
Heart rate.txt,26.5,1.40E-21,1.50E-19,8,9,10,9,10,0
Social autistic-like traits.txt,26.5,1.40E-21,1.50E-19,2,2,2,2,2,1
Fat distribution HIV.txt,26.2,2.50E-21,2.80E-19,2,2,2,2,1,1
Coffee consumption.txt,26.1,3.00E-21,3.30E-19,4,3,3,4,4,1
Chronic bronchitis in chronic obstructive pulmonary disease.txt,26,3.20E-21,3.50E-19,0,0,0,0,0,1
Magnesium levels.txt,25.9,3.80E-21,4.00E-19,3,3,3,3,5,1
Facial morphology.txt,25.9,3.90E-21,4.10E-19,1,1,1,1,1,1
Wegeners granulomatosis.txt,25.8,5.20E-21,5.40E-19,0,0,0,1,0,1
Monocyte early outgrowth colony forming units.txt,25.7,6.60E-21,6.80E-19,1,1,1,1,1,1
Non-word repetition.txt,25.5,9.60E-21,9.80E-19,2,2,2,2,2,1
Periodontitis Mean PAL.txt,25.4,1.10E-20,1.10E-18,16,16,16,16,15,0
Callous-unemotional behaviour.txt,25.2,1.50E-20,1.50E-18,1,1,0,0,0,1
Mean platelet volume.txt,25,2.30E-20,2.30E-18,17,14,15,15,16,0
Neuroticism.txt,24.7,3.70E-20,3.70E-18,6,5,5,5,6,1
Freckling.txt,24.7,4.10E-20,4.00E-18,0,0,0,0,0,1
Gastric adenocarcinoma histologically verified.txt,24.4,6.60E-20,6.40E-18,0,0,0,0,0,1
HDL Cholesterol - Triglycerides HDLC-TG.txt,24.3,7.90E-20,7.50E-18,0,0,1,0,0,1
IgE grass sensitization.txt,24,1.50E-19,1.40E-17,3,2,2,3,3,1
Intracranial aneurysm.txt,23.8,2.20E-19,2.00E-17,3,4,4,4,3,1
Staphylococcus aureus infection.txt,23.8,2.20E-19,2.00E-17,0,0,0,0,0,1
HIV-1 susceptibility.txt,23.7,2.90E-19,2.60E-17,0,1,0,1,0,1
Phosphorus levels.txt,23.6,3.00E-19,2.70E-17,0,0,0,0,0,1
IgG glycosylation.txt,23.5,3.70E-19,3.30E-17,21,23,23,23,22.5,0
Mean arterial pressure alcohol consumption interaction.txt,23.5,3.70E-19,3.30E-17,0,0,0,0,0,1
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor.txt,23.4,5.00E-19,4.40E-17,6,6,6,6,6,1
Circulating phylloquinone levels.txt,23.3,5.20E-19,4.50E-17,0,1,0,1,0,1
Diffuse large B cell lymphoma.txt,23.2,7.10E-19,6.00E-17,2,2,2,2,2,1
Diastolic blood pressure alcohol consumption interaction.txt,23.1,7.40E-19,6.20E-17,1,0,1,0,1,1
Plasma renin activity levels.txt,23,1.00E-18,8.50E-17,2,2,2,3,2,1
Matrix metalloproteinase levels.txt,22.7,1.70E-18,1.40E-16,1,0,1,1,1,1
Chronic obstructive pulmonary disease severe.txt,22.6,1.90E-18,1.50E-16,1,2,1,1,1,1
Suicide behavior.txt,22.6,2.00E-18,1.60E-16,1,2,2,1,2,1
White wine liking.txt,21.8,8.70E-18,6.90E-16,0,0,0,0,0,1
Alzheimers disease late onset.txt,21.7,1.10E-17,9.30E-16,11,8,8,7,10,1
Iron status biomarkers iron levels.txt,21.4,1.90E-17,1.50E-15,2,2,3,2,3,1
Fasting insulin interaction.txt,21.4,2.20E-17,1.60E-15,2,3,3,3,3,1
"Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative.txt",21,4.10E-17,3.00E-15,0,0,0,0,0,1
Ulcerative colitis.txt,20.8,6.30E-17,4.70E-15,48,53,51,52,48,0
Attention deficit hyperactivity disorder combined symptoms.txt,20.5,1.10E-16,8.20E-15,12,12,12,13,14,0
Childhood and early adolescence aggressive behavior.txt,20.1,2.20E-16,1.60E-14,0,0,0,0,0,1
Androgen levels.txt,20,3.10E-16,2.20E-14,2,2,2,2,2,1
Nephrotic syndrome acquired.txt,19.7,4.90E-16,3.40E-14,0,0,0,0,0,1
Medication adherence in chronic diseases.txt,19.7,5.40E-16,3.70E-14,0,0,0,0,0,1
Interferon alpha levels in systemic lupus erythematosus.txt,19.7,5.50E-16,3.70E-14,0,0,0,0,0,1
Myasthenia gravis.txt,19,1.80E-15,1.20E-13,1,1,1,1,1,1
Homeostasis model assessment of insulin resistance interaction.txt,18.9,2.30E-15,1.50E-13,3,4,3,3,3,1
Serum prostate-specific antigen levels.txt,18.7,3.50E-15,2.30E-13,4,4,4,4,4,1
Bone mineral density spine.txt,18.1,1.00E-14,6.90E-13,9,9,9,9,11,0
Vitamin E levels.txt,18,1.20E-14,7.60E-13,0,0,0,0,0,1
Molar-incisor hypomineralization.txt,17.9,1.50E-14,9.70E-13,1,1,0,0,0,1
Red blood cell traits.txt,17.6,2.60E-14,1.60E-12,10,10,10,9,9,0
Vascular endothelial growth factor levels.txt,17.6,2.60E-14,1.50E-12,0,1,1,1,1,1
Gait variability.txt,17.6,2.80E-14,1.60E-12,1,1,1,1,0,1
Monocyte count.txt,17,7.90E-14,4.60E-12,1,1,1,1,0,1
Telomere length.txt,16.8,1.20E-13,7.30E-12,2,3,3,3,3,1
Tandem gait.txt,16.3,3.30E-13,1.90E-11,2,2,2,2,2,1
Illicit drug use.txt,16.3,3.40E-13,1.90E-11,2,1,1,2,1,1
Trichloroethylene-induced hypersensitivity syndrome.txt,16,5.90E-13,3.20E-11,0,0,0,0,0,1
Alzheimers disease APOE e4 interaction.txt,15.9,6.10E-13,3.20E-11,0,1,1,1,1,1
Refractive astigmatism.txt,15.8,7.80E-13,4.00E-11,5,5,5,5,4,1
CD Crohn's disease from AV.txt,15.8,7.90E-13,4.00E-11,28,27,28,28,28,0
Asthma sex interaction.txt,15.7,9.20E-13,4.60E-11,0,2,1,1,1,1
Nevirapine-induced rash.txt,15.5,1.30E-12,6.40E-11,0,0,0,0,0,1
Optic nerve measurement cup-to-disc ratio.txt,15.2,2.60E-12,1.20E-10,1,1,1,1,1,1
Waist-to-hip circumference ratio interaction.txt,15.2,2.60E-12,1.20E-10,3,3,3,3,3,1
Follicular lymphoma.txt,15.1,3.20E-12,1.40E-10,0,0,0,0,0,1
Plasma thyroid-stimulating hormone levels.txt,14.9,4.20E-12,1.90E-10,0,0,1,0,1,1
Hypospadias.txt,14.9,4.80E-12,2.10E-10,3,3,3,3,2,1
Gait rhythm.txt,14.8,5.40E-12,2.30E-10,1,1,1,1,0,1
Febrile seizures.txt,14.7,6.80E-12,2.80E-10,3,3,3,3,3,1
Helicobacter pylori serologic status.txt,14.2,1.70E-11,7.10E-10,1,0,0,1,1,1
Febrile seizures MMR vaccine-related.txt,14.2,1.80E-11,7.20E-10,5,5,5,5,4,1
Ankylosing spondylitis.txt,13.8,3.20E-11,1.20E-09,6,6,6,7,6,1
Trans fatty acid levels.txt,13.1,1.40E-10,5.40E-09,53,53,53,54,52.5,0
Iron status biomarkers transferrin saturation.txt,12.4,5.40E-10,2.00E-08,2,2,3,2,3,1
Creatinine levels.txt,12.3,6.40E-10,2.30E-08,0,0,0,0,0,1
Liver enzyme levels alkaline phosphatase.txt,12.2,6.80E-10,2.40E-08,1,1,1,1,1,1
Suicidal ideation in depression or bipolar disorder.txt,12,9.80E-10,3.30E-08,1,1,1,1,1,1
Hair morphology.txt,11.7,1.80E-09,6.10E-08,6,4,5,4,6,1
Intracerebral hemorrhage.txt,11.7,1.90E-09,6.10E-08,2,1,1,1,1,1
Warfarin maintenance dose.txt,11.5,2.70E-09,8.40E-08,4,4,4,3,3,1
Iris characteristics.txt,11,7.30E-09,2.20E-07,4,4,4,4,4,1
Tuberculosis.txt,10.9,8.10E-09,2.30E-07,2,2,2,1,1,1
Suicide.txt,10.8,9.20E-09,2.50E-07,1,1,1,1,1,1
Periodontal microbiota.txt,10.7,1.20E-08,3.20E-07,3,3,4,4,4,1
Maximal oxygen uptake response.txt,10.6,1.50E-08,4.00E-07,0,0,0,0,0,1
Vein graft stenosis in coronary artery bypass grafting.txt,10.4,2.20E-08,5.60E-07,0,0,0,0,0,1
Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced.txt,10.2,2.90E-08,7.00E-07,0,0,0,0,0,1
Bipolar disorder with mood-incongruent psychosis.txt,10.1,3.90E-08,9.10E-07,1,1,1,0,0,1
Hormone measurements.txt,9,2.70E-07,6.00E-06,0,1,1,0,0,1
Sporadic pituitary adenoma.txt,8.4,9.80E-07,2.00E-05,0,0,0,0,0,1
Birdshot chorioretinopathy.txt,8.2,1.20E-06,2.50E-05,0,0,0,0,0,1
Platelet aggregation.txt,7.9,2.10E-06,4.00E-05,3,2,2,2,2,1
Diabetic nephropathy in type 1 diabetes.txt,7.9,2.40E-06,4.40E-05,1,1,1,1,2,1
Sleep depth.txt,7.6,3.70E-06,6.30E-05,1,1,1,1,1,1
Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms.txt,7.4,6.10E-06,9.70E-05,11,9,10,9,11,0
Serum protein levels sST2.txt,7.3,7.20E-06,0,0,2,2,2,2,1
Atrioventricular conduction.txt,6.6,2.60E-05,0,1,1,1,1,2,1
Liver enzyme levels gamma-glutamyl transferase.txt,6.3,4.10E-05,0,8,8,7,8,8,1
Carotid atherosclerosis in HIV infection.txt,5.9,8.50E-05,0.001,1,1,0,1,1,1
Coronary artery calcification.txt,4.6,0.001,0.006,37,34,35,35,35,0
Atopic dermatitis.txt,4.2,0.002,0.01,9,9,10,9,10,0
Duodenal ulcer.txt,4.1,0.002,0.01,1,1,1,1,1,1
Thyroid volume.txt,4.1,0.002,0.01,1,1,1,1,1,1
Diastolic blood pressure.txt,2.5,0.04,0.08,12,11,10,11,10,0
Pyoderma gangrenosum in inflammatory bowel disease.txt,2.3,0.052,0.08,1,0,0,0,0,1
Menopause age at onset.txt,498.8,1.7e-316,1.4e-313,6,6,6,5,6,1
Migraine with aura.txt,487.7,4.0e-311,3.30E-308,3,1,1,2,2,1
Corneal astigmatism.txt,510.2,5.6e-324,4.6e-319,6,6,6,5,4,1
Conduct disorder symptom count.txt,491.4,6.4e-313,5.2e-310,2,1,1,1,1,1
Longevity 90 years and older.txt,507.7,9.4e-321,7.7e-318,6,4,4,5,4,1
